Primer: establishing a clinical trial unit--obtaining studies and patients.
Rheumatologists with clinical expertise should perform clinical investigations of new molecules in an effort to discover therapies that could be of greater benefit or safety than those currently available for patients with chronic rheumatic diseases. Over the past few years, many studies have been conducted outside the United States and Europe because of the dearth of investigative sites in these countries. A clinician, whether in private practice or academia, who has the resources and desire to conduct clinical investigations, should be able to become involved in the process. The task of starting a new investigative unit is daunting, as it involves acquiring studies, hiring staff and obtaining space prior to any cash flow. If done properly, however, clinical investigation can be rewarding--both intellectually and financially.
University of Texas Southwestern Medical Center, Dallas, TX, USA. rfleischmann@arthdocs.com
Roy
R
Fleischmann
D002017:Budgets / Q000458:organization & administration; D002986:Clinical Trials as Topic; D032982:Contracts / Q000191:economics; D006801:Humans; D018579:Patient Selection; D011216:Practice Management, Medical / Q000191:economics / Q000458:organization & administration*; D012219:Rheumatology / Q000191:economics / Q000458:organization & administration*